# Cecropia (Cecropia obtusifolia)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/cecropia
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-28
**Evidence Score:** 2 / 10
**Category:** Amazonian
**Also Known As:** Cecropia, Trumpet tree, Guarumo, Yarumo, Cecropia peltata, Snake wood tree, Trumpet wood, Embauba, Chancarro, Hormiguillo

## Overview

Cecropia obtusifolia is an Amazonian medicinal plant whose primary bioactive compounds — isoorientin and chlorogenic acid — inhibit alpha-glucosidase and modulate insulin signaling pathways to lower [blood glucose](/ingredients/condition/weight-management). Clinical evidence supports its use as an adjunct hypoglycemic and lipid-lowering agent in type 2 diabetes management.

## Health Benefits

• Reduces fasting [blood glucose](/ingredients/condition/weight-management) by 15.25% in type 2 diabetes patients [1]. • Lowers cholesterol by 14.62% and triglycerides by 42% in clinical trials [1]. • Sustains glucose reduction in newly diagnosed type 2 diabetes patients [4]. • Exhibits [hepatoprotective](/ingredients/condition/detox) properties in animal models [2]. • Promotes insulin secretion and glucose uptake in cellular studies [2][5].

## Mechanism of Action

Isoorientin, a C-glycosyl flavone in Cecropia obtusifolia leaves, inhibits alpha-glucosidase and alpha-amylase enzymes in the intestinal brush border, slowing carbohydrate [digestion](/ingredients/condition/gut-health) and reducing postprandial glucose spikes. Chlorogenic acid activates AMPK signaling and reduces hepatic glucose output by downregulating glucose-6-phosphatase and phosphoenolpyruvate carboxykinase (PEPCK) expression. Additionally, these compounds exhibit PPAR-gamma agonist activity, improving peripheral [insulin sensitivity](/ingredients/condition/weight-management) and contributing to the observed triglyceride-lowering effects.

## Clinical Summary

A key clinical trial in newly diagnosed type 2 diabetes patients demonstrated that Cecropia obtusifolia leaf extract reduced fasting [blood glucose](/ingredients/condition/weight-management) by 15.25% and sustained this reduction over the study period, with cholesterol declining by 14.62% and triglycerides by 42%. Study sample sizes in published human trials have been modest, generally under 50 participants, which limits the generalizability of findings. Animal model studies corroborate [hepatoprotective](/ingredients/condition/detox) effects, showing reduced liver enzyme markers and [lipid peroxidation](/ingredients/condition/antioxidant), though human replication is lacking. Overall, the evidence is promising but preliminary, requiring larger randomized controlled trials before firm clinical recommendations can be made.

## Nutritional Profile

Cecropia obtusifolia leaves contain bioactive compounds primarily responsible for its metabolic effects. Key constituents include: chlorogenic acid (the predominant phenolic compound, reported at approximately 1.2–3.5 mg/g dry weight), isoorientin (a C-glycosyl flavone, ~0.8–2.1 mg/g dry weight), and orientin, which collectively contribute to its hypoglycemic and hypolipidemic actions. Procyanidins and other condensed tannins are present at approximately 2–5% of dry leaf weight, contributing to [hepatoprotective](/ingredients/condition/detox) and [antioxidant activity](/ingredients/condition/antioxidant). Ursolic acid and oleanolic acid (pentacyclic triterpenes) have been identified and are associated with insulin secretagogue effects observed in cellular studies. Fiber content in leaf preparations is moderate, estimated at 10–18% of dry weight, which may contribute to slowed glucose absorption. Mineral content includes potassium (~12–18 mg/g dry weight), calcium (~8–14 mg/g dry weight), and magnesium (~2–4 mg/g dry weight), with trace amounts of zinc and iron. Protein content is relatively low (~5–8% dry weight). Flavonoid bioavailability is enhanced in aqueous extracts (traditional decoction form), as isoorientin and chlorogenic acid demonstrate reasonable intestinal absorption, though first-pass [metabolism](/ingredients/condition/weight-management) reduces systemic concentrations; co-ingestion with food may modestly reduce peak absorption of chlorogenic acid. Vitamin C has been detected in small amounts in fresh material but degrades substantially with drying and boiling.

## Dosage & Preparation

Clinically studied dosages include a daily aqueous infusion standardized to 2.99 mg chlorogenic acid/g for 21 days in type 2 diabetics. Another study utilized daily leaf extracts for 32 weeks. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Cecropia obtusifolia is generally well tolerated at doses used in traditional medicine, but its glucose-lowering activity creates a clinically significant risk of hypoglycemia when combined with metformin, sulfonylureas, or insulin. Co-administration with other lipid-lowering agents such as statins warrants monitoring due to additive effects on cholesterol pathways. Pregnant and breastfeeding women should avoid use, as no safety data exist for these populations and uterotonic effects have been noted in traditional ethnobotanical literature. Individuals with hepatic conditions should use caution despite the [hepatoprotective](/ingredients/condition/detox) animal data, as human hepatic safety has not been formally evaluated.

## Scientific Research

A double-blind RCT involving 43 patients demonstrated significant glucose and lipid reductions with Cecropia obtusifolia leaf infusion (PMID: 15636168). An open-label study confirmed glucose reduction effects over 32 weeks (PMID: 17291702).

## Historical & Cultural Context

Cecropia obtusifolia has been traditionally used in Mexican, Central, and South American folk medicine for treating type 2 diabetes, hypertension, and [inflammation](/ingredients/condition/inflammation). It plays a significant role in Latin American medicinal practices.

## Synergistic Combinations

Berberine, Gymnema sylvestre, Cinnamon, Alpha-lipoic acid, Bitter melon

## Frequently Asked Questions

### How much does Cecropia obtusifolia lower blood sugar?

In clinical trials involving newly diagnosed type 2 diabetes patients, Cecropia obtusifolia reduced fasting blood glucose by approximately 15.25%. This effect is attributed primarily to isoorientin's inhibition of intestinal alpha-glucosidase and chlorogenic acid's suppression of hepatic glucose production via AMPK activation.

### What is the active compound in Cecropia obtusifolia?

The primary bioactive compounds are isoorientin, a C-glycosyl flavone, and chlorogenic acid, a hydroxycinnamic acid derivative. Isoorientin is responsible for most of the alpha-glucosidase inhibitory activity, while chlorogenic acid contributes to both glucose regulation and the lipid-lowering effects observed in trials.

### Can Cecropia obtusifolia lower cholesterol and triglycerides?

Yes — clinical data show Cecropia obtusifolia reduced total cholesterol by 14.62% and triglycerides by 42% in type 2 diabetes patients. The triglyceride reduction is thought to involve PPAR-gamma pathway modulation and reduced hepatic lipogenesis driven by chlorogenic acid and flavonoid constituents.

### Is Cecropia obtusifolia safe to take with diabetes medications?

Cecropia obtusifolia should be used cautiously alongside antidiabetic drugs like metformin, glipizide, or insulin due to additive hypoglycemic effects that may cause blood sugar to drop dangerously low. Patients should monitor blood glucose closely and consult a healthcare provider before combining this supplement with any prescribed glucose-lowering therapy.

### What part of the Cecropia obtusifolia plant is used medicinally?

The leaves of Cecropia obtusifolia are the primary medicinal part used, traditionally prepared as aqueous decoctions or standardized extracts in clinical research. Leaf extracts contain the highest concentrations of isoorientin and chlorogenic acid, which are the compounds responsible for the documented hypoglycemic and hypolipidemic effects.

### Is Cecropia obtusifolia safe during pregnancy and breastfeeding?

There is insufficient clinical data on Cecropia obtusifolia use during pregnancy and breastfeeding, so it is not recommended during these periods as a precaution. Pregnant and nursing women should consult with a healthcare provider before using this herb, as traditional use does not guarantee safety in these sensitive populations. No established safety profile exists for fetal or infant exposure to this ingredient.

### What is the typical dosage range for Cecropia obtusifolia supplements?

Common dosing for Cecropia obtusifolia leaf extract ranges from 1.5 to 3 grams daily in divided doses, though optimal dosing has not been standardized in clinical guidelines. Dosage may vary depending on the form (tea, extract, or powder) and the concentration of active compounds. It is advisable to start with lower doses and follow manufacturer recommendations or consult a healthcare provider for personalized dosing.

### How does Cecropia obtusifolia compare to metformin for blood sugar control?

While Cecropia obtusifolia reduces fasting blood glucose by 15.25% in clinical trials, metformin is a pharmaceutical standard that typically achieves greater glycemic control with more robust long-term safety data. Cecropia obtusifolia may serve as a complementary approach in traditional medicine but should not replace prescription diabetes medications without medical supervision. The two may have synergistic effects, but this requires clinical confirmation and medical oversight.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*